Anya Biopharm Inc. (TPEX:7776)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
32.35
+1.45 (4.69%)
At close: Sep 2, 2026

Anya Biopharm Ratios and Metrics

Millions TWD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
1,5962,3471,849--
Market Cap Growth
-48.90%26.96%---
Enterprise Value
1,2821,9631,385--
Last Close Price
32.5047.8037.65--

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
PS Ratio
122.18144.2585.60--
PB Ratio
4.575.833.96--
P/TBV Ratio
4.645.914.00--

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
EV/Sales Ratio
98.16120.6764.11--

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
Debt / Equity Ratio
0.010.010.01-1.24-1.18
Net Debt / Equity Ratio
-0.90-0.91-0.96-1.10-1.14
Net Debt / EBITDA Ratio
3.506.4610.69-3.25-1.63
Net Debt / FCF Ratio
4.115.1914.94-3.78-1.42
Asset Turnover
0.030.040.090.14-
Quick Ratio
64.9147.2741.450.110.05
Current Ratio
67.6647.9541.590.120.09
Return on Equity (ROE)
-13.14%-14.72%-19.20%--
Return on Assets (ROA)
-14.84%-8.14%-10.64%-105.84%-
Return on Capital Employed (ROCE)
-25.90%-14.40%-9.10%34.40%71.50%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
Earnings Yield
-3.08%-2.73%-2.00%--
FCF Yield
-4.79%-3.02%-1.63%--
Buyback Yield / Dilution
0.27%-48.38%-1351.36%--